OPEN REVIEW Experimental Molecular Medicine 2017 49 e305 doi101038emm201723 2017 KSBMB All rights reserved 2092641317 wwwnaturecomemm From rabbit antibody repertoires rabbit monoclonal antibodies Justus Weber Haiyong Peng Christoph Rader In review explain rabbit monoclonal antibodies outstanding reagents laboratory research increasingly diagnostic therapeutic applications Starting unique ontogeny rabbit B cells affords highly distinctive antibody repertoires rich vivo pruned binders high diversity afﬁnity speciﬁcity generation rabbit monoclonal antibodies hybridoma technology phage display alternative methods account successful humanization strategies Experimental Molecular Medicine 2017 49 e305 doi101038emm201723 published online 24 March 2017 INTRODUCTION European rabbits Oryctolagus cuniculus Figure 1 played important role animal models immunology decades12 Today rabbits major source wide variety monoclonal antibodies mAbs polyclonal antibodies pAbs broad utility pAbs described set different antibodies generated response speciﬁc pathogen antigen generally targeting different epitopes mAbs hand contain deﬁned antigenbinding site paratope typically binds high afﬁnity speciﬁcity epitope From pharma ceutical point view mAbs provide molecularly deﬁned reproducible product pAbs traditionally impre cise mixture different antibodies3 As case mouse human mAbs IgG common isotype rabbit mAbs Figure 2 Rabbit pAbs extensively analytical tools biomedical research especially immunological techni ques immunohistochemistry IHC western blotting ﬂow cytometry Rabbit pAbs utilized important tool food safety assessments4 In addition rabbit pAbs clinical context A prominent example antithymocyte globulin ATG ATG mixture puriﬁed polyclonal rabbit horse goat IgGs human T cells immunosuppressive drug decades In organ allogeneic bone marrow transplantation ATG application causes rapid depletion T cells leading decreased risk rejection acute graftversushost disease However ATG induce longterm tolerance5 Rabbit ATG commonly ATGs higher lymphocytotoxicity compared horse ATG6 Rabbit ATG known Thymoglobulin Sanoﬁ Genzyme Inc Cam bridge MA USA approved US Food Drug Administration FDA 1998 More recently improved rabbit pAbs cocktail targeting human leukocytes reported potential immunosuppressive drug xenogeneic example pig human organ transplantation7 In addition rabbit pAb currently approved FDA vitro diagnostic tool cKit pharmDx Agilent Technologies Inc Santa Clara CA USA IHCbased detection CD117 ckit expression gastrointestinal stromal tumors aid treatment decisions8 mAbs mAbderived antibody therapeutics910 currently widely treat human diseases cancer autoimmune diseases1112 Although therapeutic rabbit mAbs approved FDA far 11 rabbit mAbs FDAapproved vitro diagnostic tools clinic1314 Ten mAbs detect expression tumorassociated antigens including HER2 estrogen receptors progesterone receptors PDL1 One mAb detect helicobacter pylori infections A rabbit mAb human androgen receptor splice variant 7 emerged promising tool cells immunoﬂuorescence IHC prostate cancer1516 In addition rabbit mAbderived therapeutics currently investigated clinical trials registered ClinicalTrials gov In oncology examples include sevacizumab Simcere Pharmaceutical Group Inc Nanjing China humanized detection circulating tumor Department Immunology Microbiology The Scripps Research Institute Jupiter FL USA Correspondence Dr C Rader Department Immunology Microbiology The Scripps Research Institute Jupiter FL 33458 USA Email craderscrippsedu Received 7 December 2016 accepted 22 December 2016 2 Rabbit antibodies J Weber et al Figure 1 Oryctolagus cuniculus Shown individual b9 κlightchain allotype pedigreed noninbred colony rabbits developed characterized US National Institute Allergy Infectious Diseases National Institutes Health The rabbits currently housed rabbitry Stanwood WA USA owned R R Research Inc available custom immunization harvests peripheral blood spleen bone marrow Photo courtesy Dr Rose G Mage rabbit antihuman vascular endothelial growth factor mAb NCT024534641718 APX005M Apexigen Inc San Carlos CA USA humanized rabbit antihuman CD40 mAb NCT02482168 YYB101 humanized rabbit anti human HGF mAb YooYoung Pharmaceutical Co Inc Seoul Korea NCT024992241920 Further chimeric antigen receptor T cells based rabbit antihuman ROR1 mAb21 trials recently NCT027063922223 In commenced clinical ophthalmology humanized rabbit antivascular endothelial growth factor mAb brolucizumab Alcon Inc Hünenberg Switzerland mAb scFv format administered intravitreally investigated advanced clinical trials NCT02307682 NCT0243432824 Following examples number rabbit mAbderived therapeutics expected transition preclinical clinical studies near future Currently handful companies develop rabbit rabbitderived mAbs laboratory research diagnostic therapeu tic applications Some companies global market Abcam Inc Cambridge UK RabMAb platform acquisition Epitomics Inc Burlingame CA USA 2012 Alcon Inc acquisition ESBAtech Inc Schlieren Switzerland 2009 Apexigen Inc San Carlos CA USA spun Epitomics Inc 2010 Cell Signaling Technol ogy Inc Danvers MA USA currently listing 44000 different rabbit mAbs Agilent Technologies Inc MAB Discovery Inc Neuried Germany Lab Vision Corporation Inc Fremont CA USA Thermo Fisher Scientiﬁc Inc Carlsbad CA USA Invitrogen ABﬁnity recombinant rabbit antibodies Ventana Medical Systems Inc Tucson AZ USA Experimental Molecular Medicine Figure 2 Schematic drawing natural rabbit antibodies IgG format The 150kDa rabbit IgG molecule contains identical κ white λ light gray light chains paired identical heavy chains dark gray The light chain consists Nterminal variable domain VL shown CDRs followed constant domain CL The heavy chain consists Nterminal variable domain VH shown CDRs followed constant domains CH1 CH2 CH3 CH1 CH2 linked ﬂexible hinge region aminoacid sequence APSTCSKPTCP APSTCSKPMCP allotypic variant anchors disulﬁde bridges orange IgG molecule light heavychain pairs heavychain pair Notably rabbits κ light chains K1 K2 The frequent κ light chain K1 contains CL Rabbits commonly New Zealand White strain 90 IgGκ K1 10 IgGκ K2 o1 IgGλ antibodies CDR complementaritydetermining region disulﬁde additional bridge links VL What attraction rabbit antibodies applica tions discussed Rabbits investigate immunological questions develop immunological techniques 4100 years Thus standard procedures established published validated immunization puriﬁcation methods yielding high amounts rabbit antibodies25 In addition practical considerations rabbits characterized variety natural features antibody repertoire attractive discussed applications First rabbits belong order Lagomorpha evolutionary distinct order Rodentia example mice rats belong2629 Rabbit antibodies able recognize epitopes human antigens immunogenic rodents30 increasing total number targetable epitopes facilitating generation antibodies crossreact mouse orthologs human antigens3133 This important aspect basic research preclinical example human tumor xenografts presence absence ontargetoff tumor toxicities therapeutic antibodies provides important information prior clinical translation In general rabbit antimouse reactivity valuable mouse models human disease exploited basic research example mouse stem cell antigens3436 Second observed rabbits elicit strong immune responses small molecules haptens uncommon rodents183741 A important aspect scarcity inbred rabbit strains mouse strains inbred142 It inbred strains diverse immune responses makes difﬁcult investigations general elicit thought raise strong diverse binders18 Correspondingly IHC studies compared rabbit mouse mAbs human antigens rabbit mAbs consistently revealed higher sensitivity4362 In recent study63 1410 rabbit mAbs raised 15aminoacid peptides representing 100 different revealed typical afﬁnity range 20200 pM antigens median 66 pM determined highthroughput surface plasmon resonance A fraction rabbit mAbs revealed higher afﬁnities near detection limit 1 pM However afﬁnity range 46 mouse mAbs 30300 pM median 72 pM analyzed parallel signiﬁcantly different63 More direct comparisons rabbit mouse mAbs wider variety antigens warranted determine signiﬁcant difference afﬁnity Fourth strategies generate mAbs based recovery B cells spleen bone marrow blood present higher quantities rabbits mice overall larger body size The average body weight 3monthold laboratory rabbit 25 compared 25 g 6weekold laboratory mouse For example 50 times spleen B cells recovered rabbits compared mice18 In addition larger blood volume rabbits compared mice facilitates mass spectrometry analyses bulk serum IgG64 Fifth discussed section rabbits use different mechanisms genetically generate diversify primary secondary antibody repertoires compared humans mice effectively creating comple mentary set binders discussed applications The recent sequencing annotation rabbit genome OryCun20 assembly provided new insights unique antibody repertoire16566 ONTOGENY OF RABBIT BCELL AND ANTIBODY REPERTOIRES The development rabbit Bcell repertoire signiﬁcantly differs mammals The current model proposes threestep process Figure 3 consisting neonatal Bcell repertoire generated B lymphopoiesis fetal liver omentum switching bone marrow birth primary preimmune Bcell repertoire evolving ﬁrst 2 months birth gutassociated lymphoid tissue GALT secondary immune Bcell repertoire gener ated Bcell activation immunogen binding267 The neonatal Bcell repertoire starts developing second week gestation6869 Interestingly B lymphopoiesis limited bone marrow adult rabbits70 indicating B lymphopoiesis mainly restricted early development However B cells germline antibody sequences adult spleen71 In addition rabbittorabbit adoptive transfer model shown rabbit B cells able engraft host stem cell niches72 led conclusion rabbit B cells longlived potentially selfrenewing sustain rabbit antibody repertoire rabbits lifetime73 Rabbits mainly rearrange heavy chains ﬁrst followed light chains74 follow primary Bcell development pathway proposed Ehlich et al75 In brief Rabbit antibodies J Weber et al 3 Figure 3 Ontogeny rabbit Bcell antibody repertoires The principally different developmental stages Bcell antibody diversiﬁcation rabbit shown GALT gutassociated lymphoid tissue SGC somatic gene conversion SHM somatic hypermutation model proposes VHDJH recombination heavy chain followed expression preBcell receptor Upon preBcell receptor VLJL lightchain stimulation recombination started Some evidence nontemplated nucleotideaddition known Nnucleotides observed rabbit VκJκ rearrangements 1dayold rabbits transferase terminal deoxynucleotidyl suggesting recently expressed76 Although potential pool 200 VH genes present heavychain rearrangement6677 majority infre quently expressed78 There 1020 D genes 45 JH genes79 However known certain genes clusters preferentially utilized VH1 present 8090 heavy Dproximal VH gene chain gene rearrangements687980 Three different allotypes resulting VHa1 VHa2 VHa3 known VHapositive serotype8182 The remaining 1020 heavy chains contain VHx VHy VHz genes8384 This ﬁnding somewhat surprising functional Dproximal VH sequence VH1 segment Indeed shown VH4 segment utilized 8090 heavychain rearrangements VH1negative Alicia strain rabbits However heavychain rearrangement rare adult rabbits suggesting VH4 rearrangement nonproductive cases lost course development69 Lanning et al73 suggested negative selfantigen effects nonefﬁcient pairing light chains surrogate light chains Bcell development possible reasons In addition preferential utilization D2a D2b D1 JH4 shown79 signiﬁcantly closer It thought rabbits compensate preferential utilization certain VH D JH genes VHD DJH junctions Nnucleotide addition recombination6869 Using highthroughput sequencing antibody repertoires New Zealand White rabbits Lavinder et al85 determined mean sd length complementaritydetermining region CDR heavy chain known HCDR3 includes junctions hypervariable CDRs 15 4 mode 13 amino acids compared mouse Experimental Molecular Medicine 4 Rabbit antibodies J Weber et al human HCDR3s mean sd lengths 11 2 mode 10 amino acids 15 4 mode 15 amino acids respectively These ﬁndings conﬁrmed rabbit HCDR3s share similarity human HCDR3s mouse HCDR3s relevant therapeutic applications86 Although limited heavychain usage neonatal rabbits Bcell repertoire compensation usage diverse light chains There types rabbit light chainsκ λwith κ light chain present different isotypes called K1 K287 Four K1 κlightchain allotypesb4 b5 b6 b9have observed domes ticated rabbits Notably constant domain sequences rabbit κlightchain allotypes higher amino acid sequence diversity human Ig allotypes pairwise aminoacid sequence differences 4088 This high degree polymorphism exceeds allotypic diversity heavychain allotypes a1 a2 a3 20 aminoacid sequence differences surpasses allotypic diversity major histocompatibility complex loci1 K1 far abundant isotype represents 70 90 light chains rest usually mixture K2 λlight chains89 Many K1 light chains characterized intrachain disulﬁde bridge cysteine 80 Vκ cysteine 171 Cκ Figure 290 This additional disulﬁde bridge discovered biochemically9192 later conﬁrmed Xray crystallography9394 human mouse light chains It contribute stability rabbit antibodies peculiarities Ig evolution vertebrates This disulﬁde bridge absent rabbits K1negative Basilea mutant strain expresses K2 λlight chains Some K1 light chains rabbits homozygous b9 κlightchain allotype86 cysteine 108 Jκ thought create alternative intrachain disulﬁde bridge cysteine 171 Cκ8990 These allotypes play important role generation rabbit mAbs phage display discussed So far 50 functional Vκ genes identiﬁed7695 Recently nextgeneration sequencing rabbit antibody repertoires Kodangattil et al96 demon strated lightchain rearrangements signiﬁcantly diverse heavychain rearrangements rabbits In addi tion imprecise junction VL JL genes rabbits encompasses particularly long stretches Nnucleotides resulting average longer LCDR3s 12 2 amino acids mode 12 compared mouse human 9 1 amino acids mode 9 Figure 485 The longer rabbit LCDR3s occasionally stabilized disulﬁde bridges97 Taken generating diverse neonatal lightchain repertoire followed comparable degree diversiﬁcation primary secondary lightchain repertoires light chain compensate limited diversity heavychain repertoires rabbits This explain dominance rabbit light chain general LCDR3 particular antibodyantigen complexes dimensional structures determined Xray crystallography9497100 Experimental Molecular Medicine sequencing revealed mean sd The limited neonatal antibody repertoire diversi ﬁed week 4 8 birth resulting primary antibody repertoire67 This postnatal diversiﬁcation unusual phenomenon far observed rabbits pigs101 The main mechanisms somatic gene conversion SGC templated somatic hypermutation SHM nontemplated Figures 3 4 SGC predominantly chicken rabbit Ig gene diversiﬁcation102 leads replacement large nucleic acid sequence stretches DNA fragments nonutilized VH genes80103104 Highthroughput tract lengths 59 36 nucleotides85 Thus nonexpressible majority VH genes play important role heavychain diversiﬁcation The predominance mechanism rabbit 23 compared human 25 mouse 01 heavy chains determined highthroughput sequencing85 thought lead decreased wastage substantial portion VHDJH recombinations Nnucleotides addition outofframe junctions SGC homologous DNA recombination event105 tends favor inframe substitutions extensions89 In addition SHM observed considerable stage83106107 Following levels developmental rearrangement neonatal Bcell repertoire rabbit light chain genes undergo SGC SHM diversify repertoire Figures 3 4108 Further primary Bcell corroborating importance light chain generating antibody repertoires SGC diversity rabbit frequent 32 longer mean sd tract length 86 48 nucleotides rabbit κlight chains compared rabbit heavy chains85 Interestingly generation primary repertoire highly GALTdependent In short GALT involves uptake pathogens gastrointestinal track specialized epithelial cells known M cells presentation antigens B cells leading Bcell stimulation diversiﬁcation proliferation109 Surgical removal110 GALT tissues Peyers patches small sacculus rotundus appendix111 resulted severely immunodeﬁcient observed rabbits developed abnormal GALT112113 germfree Lanning et al114 demonstrated directly correlated reduced somatic VHDJH diversiﬁcation compared germexposed rabbits In addition intestines rabbits The secondary Bcell repertoire generated antigen dependent Bcell stimulation Again additional diversity introduced SGC SHM heavy light chains Figures 3 4115116 These events broaden Bcell repertoire directed certain set antigens associated speciﬁc pathogen73 The discussed idiotypic allotypic peculiarities rabbit antibodies extend isotype Notably rabbits IgG isotype Cγ gene compared IgG isotypes mice IgG1 IgG2a IgG2b IgG3 humans IgG1 IgG2 IgG3 IgG4 In contrast rabbits 13 Cα genes giving rise 10 functional IgA isotypes diverse IgA known1117 compared Rabbit antibodies J Weber et al 5 regularly subclone groups tried develop methods generation rabbit hybridomas This endeavor signiﬁcantly complicated absence rabbit myeloma cell lines122 Viral transforma tion rabbit B cells generate myelomalike cell lines proved difﬁcult inefﬁcient123 For reasons substantial efforts focused generating rabbitmouse heterohybridomas Unfortunately heterohybridomas generated early days hybridoma technology revealed poor fusion efﬁciency genetic instability impaired func tional rabbit heavy lightchain pairings124126 In 1988 Raybould et al122 generated ﬁrst stable rabbitmouse heterohybridoma polyethylene glycolmediated fusion rabbit spleen B cells mouse myeloma cell line SP20Ag14 Even observed stable rabbit IgG expression months groups observed genetic instability concomitant decrease mAb secretion These shortcomings partially addressed extensive rabbitmouse hetero efforts hybridoma127 The ﬁrst rabbit homohybridoma developed 1995 laboratory Katherine Knight128 In order obtain potential rabbit fusion cell line transgenic rabbits generated singlecell zygote microinjection mated generate vablcmyc double transgenic rabbits This method led discovery ﬁrst stable rabbit plasmacytoma cell line 240E1129 efﬁcient fusion partner generate rabbit homohybridomas Interestingly SpiekerPolet et al showed publication B cells derived different rabbit tissues led generation hybridomas secreting different ratios IgG IgM IgA However stability obtained homohybridomas major concern IgG secretion decreased time Although decay frequently observed mouse homohybridomas appeared drastic case rabbit homohybridomas30130 For reason Zhu Pytela121 attempted improve initial 240E1 cell line iterative subcloning screen clones higher fusion efﬁciency yielding hybridomas higher genetic stability stable rabbit IgG secretion The obtained fusion cell line 240EW successors 240EW2 240 W3 characterized higher fusion efﬁciency absence endogenous rabbit heavy lightchain secretion US Patent 742948741 proprietary RabMab platform Epitomics Inc Abcam Inc generate therapeutic rabbit mAbs sevacizumab APX005M discussed speciﬁc rabbit mAbs example highly Aside therapeutic applications rabbit mAbs generated hybridoma technology highly valuable reagents laboratory research diagnostic applications For detect activating mutations tyrosine kinase domain EGFR IHC lung cancer tissues131 Rabbit mAbs detect posttranslational modiﬁcations132133 suitable Further rabbit mAbs HIV1 protein gp120 shown mimic neutralizing human antiHIV1 gp120 mAbs promoting rabbit immunization model HIV1 vaccine development94134136 Experimental Molecular Medicine Figure 4 Molecular mechanisms sequence diversiﬁcation rabbit antibody repertoires Top VHDJH VLCL recombi nation takes place neonatal Bcell repertoire In rabbit Nnucleotide additions blue VLCL junctions encoding LCDR3 extensive VHD DJH junctions encoding HCDR3 Middle SGC events green diversify VH VL portion rabbit heavy light chains primary secondary Bcell repertoires localize regions encoding HCDR1 HCDR2 LCDR1 LCDR2 Bottom SHM events red diversify primary secondary Bcell repertoires SGC somatic gene conversion SHM somatic hypermutation rabbit heavy light chains IgA isotype mice humans Collectively unique features Bcell ontogeny antibody repertoire rabbits valuable source generation antibodies high afﬁnity speciﬁcity GENERATION OF RABBIT MABS Hybridoma technology The discovery development hybridoma technology generation mAbs Georges Köhler César Milstein 1975 huge impact biomedical research application modern medicine118119 Hybridoma technology method generate stable cell lines constantly secret deﬁned mAb For purpose B cells derived immunized animal fused myeloma cell line presence polyethylene glycol The hybridomas generated way cloned limiting dilution screened favorable mAb characteristics expanded culture obtain high amounts desired mAb119 Generally hybri doma types distinguished ﬁrst homohybridomas host B cells fusion cell line emerged species second heterohybridomas derived different species120 Ever initial discovery multiple aspects general technique modiﬁed order avoid certain problems related fusion efﬁciency hybridoma stability mAb titers121 Hybridoma technology extensively generate thousands different mAbs wide variety antigens In fact majority FDAapproved chimeric humanized human mAbs originate hybridoma technology120 However derived mouse B cells transgenic mouse B cells human Ig genes Due favorable properties rabbit antibodies 6 Rabbit antibodies J Weber et al Phage display technology Bacteriophage simply known phage viruses infect replicate bacteria Phage display invented George Smith discovered minor coat protein pIII ﬁlamentous phage modiﬁed amino terminus present peptide sequences affecting phage infectivity In addition phage particles contained genomic information encoding respectively modiﬁed coat protein physically linking genotype phenotype A combination phage selection ampliﬁcation efﬁciently enrich phage contained certain peptide sequences137 However incorporation larger peptide sequences protein domains proteins represented challenge decreasing infectivity For reason twocomponent systems developed consisted phagemid encoding pIII fusion protein helper phage contributing phage genome encode proteins necessary generating infectious phage particles Usually helper phage contain modiﬁed packaging signal leading preferential assembly phage particles containing phagemid In early 1990s ﬁrst ﬁlamentous phage display antibody libraries based pIII fusion proteins published scFv Fab fragments138139 To date formats dominating selection mAbs phage display140142 Although phage display established mouse human antibody libraries immune naive synthetic antibody repertoires120141 fact rabbit mAbs difﬁcult generate hybridoma technology number years provided strong incentive exploring accessibility rabbit immune antibody repertoires phage display The ﬁrst rabbit antibody library selected phage display reported Ridder et al143 scFv format subsequent independent studies3940144151 Rabbit antibody libraries Fab format followed short succession152153 Due higher expression levels human compared rabbit constant domains bacteria chimeric rabbithuman Fab format consisting rabbit variable domains VL VH recombinantly fused human constant domains CL CH1 respectively proved particularly successful selec tion rabbit mAbs phage display19154160 subsequent humanization Figure 5155 However discussed intrachain disulﬁde bridge cysteine 80 cysteine 171 rabbit κ light chains dominating K1 isotype posed challenge chimeric rabbithuman Fab format human CH1 harbor cysteine 171 In fact Fab originating K1 isotype selected86155 indicating free thiol group cysteine 80 disfavored presence diminishes selectable diversity chimeric rabbithuman Fab Indeed chimeric rabbithuman Fab derived phage display immunized K1negative Basilea strain rabbits revealed higher sequence diversity higher K1positive New Zealand White strain rabbits immunized immunogens86 Interestingly study Popkov et al compared rabbits homozygous afﬁnity compared Experimental Molecular Medicine Figure 5 Chimeric rabbithuman Fab humanized rabbit Fab Top contrast rabbit Fab chimeric rabbithuman Fab consist rabbit variable domains blue orange human constant domains gray white expressed Escherichia coli displayed phage The phage particle shown displays chimeric rabbithuman Fab copy linked phage surface Cterminal pIII protein domain phenotype genotype contain corresponding singlestranded phagemid encodes Fab This physical linkage phenotype genotype essence phage display Bottom following selection phage display chimeric rabbithuman Fab humanized typically involves grafting rabbit CDRs blue orange human framework regions gray white b9 κlightchain allotype Figure 1 presumed alter native intrachain disulﬁde bridge cysteine 108 cysteine 171 Fusion rabbit Vκ human Cκ encoding sequences generation chimeric rabbithuman Fab library removes cysteine 108 avoiding exposure free thiol group Consequently immunized b9 allotype rabbits revealed superior selectable diversity subsequently additional studies2132161 These include generation chimeric rabbithuman Fab HIV1 protein Rev99 The Fab able invert Rev polymerization allowed formation FabRev cocrystals analyzed Xray crystal lography providing ﬁrst threedimensional structure Rev ﬁrst threedimensional structure rabbit mAb98 Notably crystal structure revealed dominant role LCDR3 antigenbinding site Figure 6 A cyclic peptide derived LCDR3 shown bind HIV1 Rev high afﬁnity potently inhibit Rev polymerization162 corroborating functional impor tance abovediscussed high sequence diversity rabbit light chains A key advantage natural Fab format phage display robust monomeric nature permits afﬁnity driven selections142 By contrast unnatural scFv format trimerize tetramerize163164 tendency dimerize potentially causing aviditydriven selections141 Thus Rabbit antibodies J Weber et al 7 light followed In generation human mAbs prominent alternative methods include clonal expansion B cells example EpsteinBarr virus immortalization single Bcell sorting heavychainencoding DNA ampliﬁcation sequencing120 Notably like hybridoma technology unlike phage display methods yield natural isolation light heavychain pairs Single Bcell based antigen capture ﬂuorescenceactivated cell sorting magnetic beads solidphase panning hemolytic plaques followed light heavychain cloning applied generation rabbit mAbs peripheral B cells172176 require killing animal allows multiple sampling points primary secondary lymphoid tissues177 Antigen capturedriven bulk spleen Bcell isolation immunized rabbits followed light heavychainencoding DNA ampliﬁcation combinatorial assembly expression scFvFc IgG format mammalian cells reported178 In ﬂuorescent foci method plasma cells rabbit bone marrow identiﬁed ﬂuorescent microscopy isolated subjected light heavychainencoding DNA ampliﬁca tion sequencing179 Highthroughput DNA sequencing technologies applied silico generation mAbs analysis naive immune antibody repertoires different species180 In rabbit highthroughput DNA sequencing Bcell repertoires mass spectrometry analysis bulk serum IgG deconvolution mAbs64181 Interestingly method revealed serum IgG response invertebrate protein following hyperimmunization oligoclonal polyclonal comprising 34 rabbit mAbs belonging 30 distinct clonotypes64 HUMANIZATION OF RABBIT MABS The human immune intended recognize selectively remove potentially pathogenic organisms substances This true nonhuman proteins mouse rabbit mAbs The respective immune responses characterized high titers human antibodies directed foreign antibody sequences182 This main physiological consequences ﬁrst leads effects comparable allergic reactions different levels severity second leads rapid elimination adminis tered mAb therapeutic efﬁcacy183184 For reasons nonhuman mAbs routinely converted chimeric mAbs combining constant nonhuman domains185 humanized mAbs grafting CDRs nonhuman variable domains human frameworks186 limiting diagnostic domains variable human The ﬁrst chimeric humanized rabbit mAbs reported Rader et al155 In study chimeric rabbit human Fab selected phage display humanized grafting rabbit CDRs light heavy chain human frameworks diversiﬁed certain positions allow selection human rabbit Experimental Molecular Medicine Figure 6 Crystal structure chimeric rabbithuman Fab selected phage display complex HIV1 Rev PDB accession code 2X7L9899 The CDR loops heavy chain colored blue CDR loops light chain colored orange Aminoacid residue chains interact antigen gray drawn sticks Note dominating contribution LCDR3 paratope When synthesized cyclic peptide LCDR3 able bind HIV1 Rev high afﬁnity162 intrabodies recommend chimeric rabbithuman Fab formatbased phage display applications require rabbit mAbs high afﬁnity Even application calls scFv generation chimeric rabbithuman Fab format selection phage display followed conversion rabbit scFv format160165167 In addition Fab scFv formats singledomain antibody formats VL VH smaller sizes advantages certain applications recognition cryptic epitopes163 engineered rabbit mAbs168170 The noted dominance rabbit light chain phage display rabbit VL libraries particularly attractive Alternative methods As discussed hybridoma technology phage display distinct virtues shortcomings fueled devel opment alternative techniques generate mAbs Unlike hybridoma technology phage display relies proper transcription translation folding assembly light heavy chains bacteria Also potential disadvantage phage display display technologies combi natorial nature leading random pairing light heavy chains120 As discussed limiting factors encoun tered hybridoma technology initially included fusion efﬁciency hybridoma stability130171 Also unlike mouse hybridoma technology rabbit hybridoma technology patented imposing intellectual property restrictions contributed incentive developing alternative methods 8 Rabbit antibodies J Weber et al residues phage display The resulting humanized rabbit mAbs retained high afﬁnity speciﬁcity parental mAbs As discussed aside having higher utility downstream clinical applications chimeric rabbithuman Fab format phage display added advantage affording higher expression levels bacteria concomi tantly higher display levels phage155 Since ﬁrst report number additional humanized rabbit mAbs published patented In general humanization strategies worked mouse mAbs work rabbit mAbs rational design1733187 directed evolution188 combination both155189 As case mouse mAbs grafting CDRs followed iterative ﬁnetuning framework residues frequently method humanizing rabbit mAbs Borras et al general acceptor framework humanization rabbit scFv In study certain human framework carrying ﬁve speciﬁc humantorabbit mutations able generate humanized rabbit mAbs different antigens conserved afﬁnities speciﬁcities improved biophysical properties24 Humanization strategies conﬁne content parental rabbit antibody sequences hypervariable CDRs LCDR3 HCDR3190 successfully applied rabbit mAbs188 Thus far reports analyze immunogenicity clinically investigated humanized rabbit mAbs Recent studies indicate patients mount immune response humanized fully human mAbs These ﬁndings indicate additional aspects idiotype allotype glycosylation aggregation contribute immunogenicity mAbs191 Nonetheless occurrence unwanted effects previously observed nonhuman antibodies182 signiﬁcantly lower SUMMARY AND OUTLOOK Driven success rabbit pAbs hand mouse mAbs hand rabbit mAbs highly successful reagents laboratory research diagnostic therapeutic applications The unique ontogeny rabbit B cells affords highly distinctive antibody repertoires rich vivo pruned binders high diversity afﬁnity speciﬁcity The ability access rabbit antibody repertoires hybridoma technology phage display alternative methods fueled increased use rabbit mAbs different applica tions Rabbit mAbs generated hybridoma technology particularly attractive IHC studies demonstrat ing higher sensitivity compared benchmark mouse mAbs Rabbit mAbs generated phage display use applications ranging detection uranium water40 chimeric antigen receptor T cell therapy cancer22 Given humanization strategies established therapeutic utility rabbit mAbs especially intriguing With ﬁrst rabbit mAbderived therapeutics clinical trials predict rabbit mAbs gain traction preclinical clinical pipelines decade Experimental Molecular Medicine CONFLICT OF INTEREST The authors declare conﬂict ACKNOWLEDGEMENTS We thank Dr HaJeung Park preparing Figure 6 Drs Rose G Mage Weimin Zhu reading editing manuscript 1 Pinheiro A Neves F Lemos De Matos A Abrantes J Van Der Loo W Mage R et al An overview lagomorph immune genetic diversity Immunogenetics 2016 68 83107 2 Mage RG Lanning D Knight KL B cell antibody repertoire develop ment rabbits requirement gutassociated lymphoid tissues Dev Comp Immunol 2006 30 137153 3 Haurum JS Recombinant polyclonal antibodies generation 4 antibody therapeutics Drug Discov Today 2006 11 655660 Campbell K Stewart LD Doucette GJ Fodey TL Haughey SA Vilarino N et al Assessment speciﬁc binding proteins suitable detection paralytic shellﬁsh poisons optical biosensor technology Anal Chem 2007 79 59065914 6 5 Mohty M Gaugler B Mechanisms action antithymocyte globulin old dogs new tricks Leuk Lymphoma 2008 49 16641667 Thomas FT Griesedieck C Thomas J Carver M Whitley T Warren R et al Differential effects horse ATG rabbit ATG T cell T cell subset levels measured monoclonal antibodies Transplant Proc 1984 16 15611563 Zhu L Fang Y Liu Z Wang P Wang Y Xu H Rabbit antihuman leukocyte polyclonal antibody inhibits xenogeneic cellmediated immune responses Transplant Proc 2008 40 27602763 FDA Available httpwwwaccessdatafdagovscriptscdrhdevicesatfda indexcfm search term rabbit polyclonal antibodies accessed 3 October 2016 7 8 9 Reichert JM Antibodies watch 2016 MAbs 2016 8 197204 10 Weiner GJ Building better monoclonal antibodybased therapeutics Nat Rev Cancer 2015 15 361370 11 Chan AC Carter PJ Therapeutic antibodies autoimmunity inﬂammation Nat Rev Immunol 2010 10 301316 12 Scott AM Wolchok JD Old LJ Antibody therapy cancer Nat Rev Cancer 2012 12 278287 13 FDA Available httpwwwaccessdatafdagovscriptscdrhdevice satfdaindexcfm search term rabbit monoclonal antibody accessed 3 October 2016 14 Zhu W Li A Chen T Rabbit monoclonal antibodies In Lin F Prichard J eds Handbook Practical Immunohistochemistry Frequently Asked Questions SpringerVerlag New York NY USA 2015 pp 7784 15 Scher HI Lu D Schreiber NA Louw J Graf RP Vargas HA et al Association ARV7 circulating tumor cells treatmentspeciﬁc castrationresistant biomarker prostate cancer JAMA Oncol 2016 2 14411449 outcomes survival 16 Welti J Rodrigues DN Sharp A Sun S Lorente D Riisnaes R et al Analytical validation clinical qualiﬁcation new immunohisto chemical assay androgen receptor splice variant7 protein expression metastatic castrationresistant prostate cancer Eur Urol 2016 70 599608 17 Yu Y Lee P Ke Y Zhang Y Yu Q Lee J et al A humanized antiVEGF rabbit monoclonal antibody inhibits angiogenesis blocks tumor growth xenograft models PLoS ONE 2010 5 e9072 18 Feng L Wang X Jin H Rabbit monoclonal antibody potential application cancer therapy Am J Transl Res 2011 3 269274 19 Kim K Hur Y Ryu EK Rhim JH Choi CY Baek CM et al A neutralizable epitope induced HGF interaction receptor cMet Biochem Biophys Res Commun 2007 354 115121 20 Song SW Lee SJ Kim CY Song JK Jung EJ Choi YB et al Inhibition tumor growth mouse xenograft model humanized antiHGF monoclonal antibody YYB101 produced largescale CHO cell culture J Microbiol Biotechnol 2013 23 13271338 21 Yang J Baskar S Kwong KY Kennedy MG Wiestner A Rader C Therapeutic potential challenges targeting receptor tyrosine kinase ROR1 monoclonal antibodies Bcell malignancies PLoS ONE 2011 6 e21018 Rabbit antibodies J Weber et al 9 22 Hudecek M LupoStanghellini MT Kosasih PL Sommermeyer D Jensen MC Rader C et al Receptor afﬁnity extracellular domain modiﬁcations affect tumor recognition ROR1speciﬁc chimeric antigen receptor T cells Clin Cancer Res 2013 19 31533164 23 Berger C Sommermeyer D Hudecek M Berger M Balakrishnan A Paszkiewicz PJ et al Safety targeting ROR1 primates chimeric antigen receptormodiﬁed T cells Cancer Immunol Res 2015 3 206216 24 Borras L Gunde T Tietz J Bauer U HulmannCottier V Grimshaw JP et al Generic approach generation stable humanized single chain Fv fragments rabbit monoclonal antibodies J Biol Chem 2010 285 90549066 25 Ayyar BV Hearty S Okennedy R Facile domain rearrangement abrogates expression recalcitrance rabbit scFv Appl Microbiol Biotechnol 2015 99 26932703 26 Miller W Rosenbloom K Hardison RC Hou M Taylor J Raney B et al 28way vertebrate alignment conservation track UCSC Genome Browser Genome Res 2007 17 17971808 27 Matthee CA Van Vuuren BJ Bell D Robinson TJ A molecular supermatrix rabbits hares Leporidae allows identiﬁcation ﬁve intercontinental exchanges Miocene Syst Biol 2004 53 433447 28 Carneiro M Afonso S Geraldes A Garreau H Bolet G Boucher S et al The genetic structure domestic rabbits Mol Biol Evol 2011 28 18011816 29 MeloFerreira J Lemos De Matos A Areal H Lissovsky AA Carneiro M Esteves PJ The phylogeny pikas Ochotona inferred multilocus coalescent approach Mol Phylogenet Evol 2015 84 240244 30 Rief N Waschow C Nastainczyk W Montenarh M Gotz C Production characterization rabbit monoclonal antibody human CDC25C phosphatase Hybridoma 1998 17 389394 31 Yu Y Chen Y Ding G Wang M Wu H Xu L et al A novel rabbit anti hepatocyte growth factor monoclonal neutralizing antibody inhibits tumor growth prostate cancer cells mouse xenografts Biochem Biophys Res Commun 2015 464 154160 32 Popkov M Jendreyko N GonzalezSapienza G Mage RG Rader C Barbas CF 3rd Humanmouse crossreactive antiVEGF receptor 2 recombinant antibodies selected immune b9 allotype rabbit antibody library J Immunol Methods 2004 288 149164 33 Yu Y Lee P Ke Y Zhang Y Chen J Dai J et al Development humanized rabbit monoclonal antibodies vascular endothelial growth factor receptor 2 potential antitumor effects Biochem Biophys Res Commun 2013 436 543550 34 Lu Y Su Z Li Y Luo J Tan Z Ji H et al Generation characterisation rabbit monoclonal antibodies native cell surface antigens embryonic stem cells J Genet Genomics 2010 37 483492 35 Tan Z Zhang J Su Z Gu B Jiang X Luo J et al Production rabbit monoclonal antibodies mouse embryonic stem cells identiﬁ cation pluripotencyassociated surface antigens J Immunol Methods 2011 365 149157 36 Huang Y Gu B Wu R Zhang J Li Y Zhang M Development rabbit monoclonal antibody group Smads immunocytochemical study human mouse embryonic stem cells Hybridoma 2007 26 387391 37 Liu N Zhao Z Tan Y Lu L Wang L Liao Y et al Simultaneous raising rabbit monoclonal antibodies ﬂuoroquinolones diverse recognition functionalities single mixture immunization Anal Chem 2016 88 12461252 38 Liu N Han Z Lu L Wang L Ni G Zhao Z et al Development new rabbit monoclonal antibody based competitive indirect enzyme linked immunosorbent assay rapid detection sulfonamides J Sci Food Agric 2013 93 667673 39 Li Y Cockburn W Kilpatrick JB Whitelam GC High afﬁnity ScFvs single rabbit immunized multiple haptens Biochem Biophys Res Commun 2000 268 398404 40 Zhu X Kriegel AM Boustany CA Blake DA Singlechain variable scFv antibodies optimized environmental analysis fragment uranium Anal Chem 2011 83 37173724 41 Medical Device Diagnostic Industry Rabbit monoclonal antibody new diagnostics technology Available httpwwwmddionlinecom articlerabbitmonoclonalantibodynewdiagnosticstechnology posted 26 June 2013 Weimin Zhu 42 Peng X Roshwalb S Cooper TK Zimmerman H Christensen ND High incidence spontaneous cataracts aging laboratory rabbits inbred strain Vet Ophthalmol 2015 18 186190 43 Klebe S Swalling A Jonavicius L Henderson DW An immunohistochem ical comparison TTF1 monoclonal antibodies atypical squamous lesions sarcomatoid carcinoma lung pleural malignant mesothelioma J Clin Pathol 2016 69 136141 44 Hoang LL Tang P Hicks DG Chen H Yang Q Haas TS et al A new rabbit monoclonal Ecadherin antibody EP700Y shows higher sensitivity mouse monoclonal Ecadherin HECD1 antibody breast ductal carcinomas stain breast lobular carcinomas Appl Immuno histochem Mol Morphol 2014 22 606612 45 Fortunato MJ Ball CE Hollinger K Patel NB Modi JN Rajasekaran V et al Development rabbit monoclonal antibodies detection alpha dystroglycan normal dystrophic tissue PLoS ONE 2014 9 e97567 46 Kendrick SL Redd L Muranyi A Henricksen LA Stanislaw S Smith LM et al BCL2 antibodies targeted different epitopes detect varying levels protein expression correlate frequent gene ampliﬁcation diffuse large Bcell lymphoma Hum Pathol 2014 45 21442153 47 Boger C Kalthoff H Goodman SL Rocken C Validation comparison antialphavbeta3 antialphavbeta5 rabbit monoclonal versus murine monoclonal antibodies different tumor entities Appl Immunohistochem Mol Morphol 2013 21 553560 48 Taheri D Zahavi DJ Del Carmen Rodriguez M Meliti A Rezaee N Yonescu R et al For staining ALK protein novel D5F3 antibody demonstrates superior overall performance terms intensity extent staining comparison currently ALK1 antibody Virchows Arch 2016 469 345350 49 Hanley KZ Siddiqui MT Lawson D Cohen C Nassar A Evaluation new monoclonal antibodies detection estrogen receptor progesterone receptor Her2 protein expression breast carcinoma cell block sections conventional microscopy quantitative image analysis Diagn Cytopathol 2009 37 251257 50 Rocha R Nunes C Rocha G Oliveira F Sanches F Gobbi H Rabbit monoclonal antibodies higher sensitivity mouse monoclonals estrogen progesterone receptor evaluation breast cancer immunohistochemistry Pathol Res Pract 2008 204 655662 51 Rossi S Laurino L Furlanetto A Chinellato S Orvieto E Canal F et al Rabbit monoclonal antibodies comparative study novel category immunoreagents corresponding mouse monoclonal antibodies Am J Clin Pathol 2005 124 295302 52 Cheuk W Wong KO Wong CS Chan JK Consistent immunostaining cyclin D1 achieved routine basis newly available rabbit monoclonal antibody Am J Surg Pathol 2004 28 801807 53 Pruneri G Valentini S Bertolini F Del Curto B Maiorano E Viale G SP4 novel anticyclin D1 rabbit monoclonal antibody highly sensitive probe lymphomas bearing t1114 q13q32 translocation Appl Immunohistochem Mol Morphol 2005 13 318322 identifying mantle cell 54 Huang Z Zhu W Meng Y Xia H Development new rabbit monoclonal antibody progesterone receptor Clone SP2 heat pretreatment effective parafﬁn section immunohistochemistry Appl Immunohisto chem Mol Morphol 2006 14 229233 55 Cheang MC Treaba DO Speers CH Olivotto IA Bajdik CD Chia SK et al Immunohistochemical detection new rabbit monoclonal anti body SP1 estrogen receptor breast cancer superior mouse monoclonal antibody 1D5 predicting survival J Clin Oncol 2006 24 56375644 56 Guo Q Li H Gaddam SS Justice NJ Robertson CS Zheng H Amyloid precursor protein revisited neuronspeciﬁc expression highly stable nature soluble derivatives J Biol Chem 2012 287 24372445 57 Van Der Vegt B De Bock GH Bart J Zwartjes NG Wesseling J Validation 4B5 rabbit monoclonal antibody determining Her2neu status breast cancer Mod Pathol 2009 22 879886 58 Fischer T Nagel F Jacobs S Stumm R Schulz S Reassessment CXCR4 chemokine receptor expression human normal neoplastic tissues novel rabbit monoclonal antibody UMB2 PLoS ONE 2008 3 e4069 59 Qi W Chu J Zhou D Tacha D Characterization applications newly developed rabbit monoclonal antibody cytokeratin 7 CK7 immunohistochemistry Appl Immunohistochem Mol Morphol 2009 17 233238 Experimental Molecular Medicine 10 Rabbit antibodies J Weber et al 60 Wludarski SC Bacchi CE High concordance SP3 rabbit monoclonal antibody FISH evaluate HER2 breast carcinoma Appl Immunohistochem Mol Morphol 2008 16 466470 61 Powell WC Hicks DG Prescott N Tarr SM Laniauskas S Williams T et al A new rabbit monoclonal antibody 4B5 immunohistochemical IHC determination HER2 status breast cancer comparison CB11 ﬂuorescence situ hybridization FISH interlaboratory Immunohistochem Mol Morphol 2007 15 reproducibility Appl 94102 62 Ricardo SA Milanezi F Carvalho ST Leitao DR Schmitt FC HER2 evaluation novel rabbit monoclonal antibody SP3 CISH tissue microarrays invasive breast carcinomas J Clin Pathol 2007 60 10011005 63 Landry JP Ke Y Yu GL Zhu XD Measuring afﬁnity constants 1450 monoclonal antibodies peptide targets microarraybased labelfree assay platform J Immunol Methods 2015 417 8696 64 Wine Y Boutz DR Lavinder JJ Miklos AE Hughes RA Hoi KH et al Molecular deconvolution monoclonal antibodies comprise polyclonal serum response Proc Natl Acad Sci USA 2013 110 29932998 65 Carneiro M Rubin CJ Di Palma F Albert FW Alfoldi J Barrio AM et al Rabbit genome analysis reveals polygenic basis phenotypic change domestication Science 2014 345 10741079 66 Gertz EM Schaffer AA Agarwala R BonnetGarnier A RogelGaillard C Hayes H et al Accuracy coverage assessment Oryctolagus cuniculus rabbit genes encoding immunoglobulins genome sequence assembly OryCun20 localization IGH locus chromosome 20 Immunogenetics 2013 65 749762 67 Knight KL Crane MA Generating antibody repertoire rabbit Adv Immunol 1994 56 179218 68 Tunyaplin C Knight KL Fetal VDJ gene repertoire rabbit evidence Immunol 1995 25 rearrangement VH1 Eur J preferential 25832587 83 Short JA Sethupathi P Zhai SK Knight KL VDJ genes VHa2 allotype suppressed rabbits Limited germline VH gene usage accumulation somatic mutations D regions J Immunol 1991 147 40144018 84 Dipietro LA Knight KL Restricted utilization germline VH genes diversity D regions rabbit splenic Ig mRNA J Immunol 1990 144 19691973 85 Lavinder JJ Hoi KH Reddy ST Wine Y Georgiou G Systematic characterization comparative analysis rabbit immunoglobulin repertoire PLoS ONE 2014 9 e101322 86 Popkov M Mage RG Alexander CB Thundivalappil S Barbas CF 3rd Rader C Rabbit immune repertoires sources therapeutic mono clonal antibodies impact kappa allotypecorrelated variation cysteine content antibody libraries selected phage display J Mol Biol 2003 325 325335 87 Benammar A Cazenave PA A second rabbit kappa isotype J Exp Med 1982 156 585595 88 Bernstein KE Skurla RM Jr Mage RG The sequences rabbit kappa light chains b4 b5 allotypes differ constant regions 3 untranslated regions Nucleic Acids Res 1983 11 72057214 89 Mage RG Diversiﬁcation rabbit VH genes geneconversionlike hypermutation mechanisms Immunol Rev 1998 162 4954 90 MccartneyFrancis N Skurla RM Jr Mage RG Bernstein KE Kappa chain allotypes isotypes rabbit cDNA sequences clones encoding b9 suggest evolutionary pathway possible role interdomain disulﬁde bond quantitative allotype expression Proc Natl Acad Sci USA 1984 81 17941798 91 Poulsen K Fraser KJ Haber E An active derivative rabbit antibody light chain composed constant variable domains held native disulﬁde bond Proc Natl Acad Sci USA 1972 69 24952499 92 Strosberg AD Margolies MN Haber E The interdomain disulﬁde bond homogeneous rabbit pneumococcal antibody light chain J Immunol 1975 115 14221424 69 Zhu X Boonthum A Zhai SK Knight KL B lymphocyte selection age related changes VH gene usage mutant Alicia rabbits J Immunol 1999 163 33133320 93 Arai H Glabe C Luecke H Crystal structure conformationdependent rabbit IgG Fab speciﬁc amyloid preﬁbrillar oligomers Biochim Biophys Acta 2012 1820 19081914 70 Crane MA Kingzette M Knight KL Evidence limited Blymphopoiesis adult rabbits J Exp Med 1996 183 21192121 71 Sehgal D Schiaffella E Anderson AO Mage RG Analyses single B cells polymerase chain reaction reveal rearranged VH germline sequences spleens immunized adult rabbits implications B cell repertoire maintenance renewal J Immunol 1998 161 53475356 72 Yoshio T Saito K Adler FL Adler LT A role mature B cells bone marrow transplantation Immunology 1988 64 147153 73 Lanning D Zhu X Zhai SK Knight KL Development antibody repertoire rabbit gutassociated lymphoid tissue microbes selection Immunol Rev 2000 175 214228 74 Gathings WE Mage RG Cooper MD Lawton AR YoungCooper GO Immunoﬂuorescence studies expression VH allotypes preB B cells homozygous heterozygous rabbits Eur J Immunol 1981 11 200206 75 Ehlich A Schaal S Gu H Kitamura D Muller W Rajewsky K Immunoglobulin heavy light chain genes rearrange independently early stages B cell development Cell 1993 72 695704 76 Sehgal D Johnson G Wu TT Mage RG Generation primary antibody repertoire rabbits expression diverse set IgkV genes heavy compensate chain locus Immunogenetics 1999 50 3142 limited combinatorial diversity 77 Roux KH Dhanarajan P Gottschalk V Mccormick WT Renshaw RW Latent a1 VH germline genes a2a2 rabbit Evidence gene conversion germline somatic levels J Immunol 1991 146 20272036 78 Fitts MG Metzger DW Identiﬁcation rabbit genomic IgVH pseudo genes serve donor sequences latent allotype expression J Immunol 1990 145 27132717 94 Pan R Sampson JM Chen Y Vaine M Wang S Lu S et al Rabbit anti HIV1 monoclonal antibodies raised immunization mimic antigenbinding modes HIV1 infected humans J Virol 2013 87 1022110231 antibodies derived 95 Ros F Reichenberger N Dragicevic T Van Schooten WC Buelow R Platzer J Sequence analysis 04 megabases rabbit germline immunoglobulin kappa1 light chain locus Anim Genet 2005 36 5157 96 Kodangattil S Huard C Ross C Li J Gao H Mascioni A et al The functional repertoire rabbit antibodies antibody discovery generation sequencing MAbs 2014 6 628636 97 Malia TJ Teplyakov A Brezski RJ Luo J Kinder M Sweet RW et al Structure speciﬁcity antibody targeting proteolytically cleaved IgG hinge Proteins 2014 82 16561667 98 Dimattia MA Watts NR Stahl SJ Rader C Wingﬁeld PT Stuart DI et al Implications HIV1 Rev dimer structure 32 A resolution multimeric binding Rev response element Proc Natl Acad Sci USA 2010 107 58105814 99 Stahl SJ Watts NR Rader C Dimattia MA Mage RG Palmer I et al Generation characterization chimeric rabbithuman Fab cocrystallization HIV1 Rev J Mol Biol 2010 397 697708 100 Lammens A Baehner M Kohnert U Niewoehner J Von Proff L Schraeml M et al Crystal structure human TWEAK complex Fab fragment neutralizing antibody reveals insights receptor binding PLoS ONE 2013 8 e62697 101 Sun J Hayward C Shinde R Christenson R Ford SP Butler JE Antibody repertoire development fetal neonatal piglets I Four VH genes account 80 percent VH usage 84 days fetal life J Immunol 1998 161 50705078 79 Friedman ML Tunyaplin C Zhai SK Knight KL Neonatal VH D JH gene usage rabbit B lineage cells J Immunol 1994 152 632641 80 Becker RS Suter M Knight KL Restricted utilization VH DH genes 102 Mage RG Sehgal D Schiaffella E Anderson AO Geneconversion rabbit Bcell ontogeny immune responses splenic germinal centers Vet Immunol Immunopathol 1999 72 715 leukemic rabbit B cells Eur J Immunol 1990 20 397402 81 Dray S Young GO Nisonoff A Distribution allotypic speciﬁcities rabbit gammaglobulin molecules genetically deﬁned loci Nature 1963 199 5255 82 Kim BS Dray S Expression x y variable region genes heavy chains IgG IgM IgA molecules normal locus allotypesuppressed rabbits J Immunol 1973 111 750760 103 Raman C SpiekerPolet H Yam PC Knight KL Preferential VH gene usage rabbit Igsecreting heterohybridomas J Immunol 1994 152 39353945 104 Lanning DK Knight KL Somatic hypermutation mutations 3 rabbit VDJ Hchain genes J Immunol 1997 159 44034407 105 Kurosawa K Ohta K Genetic diversiﬁcation somatic gene conversion Genes 2011 2 4858 Experimental Molecular Medicine 106 Weinstein PD Anderson AO Mage RG Rabbit IgH sequences appendix germinal centers VH diversiﬁcation gene conversionlike hyper mutation mechanisms Immunity 1994 1 647659 107 Pascual V Verkruyse L Casey ML Capra JD Analysis Ig H chain gene segment utilization human fetal liver Revisiting proximal utilization hypothesis J Immunol 1993 151 41644172 108 Sehgal D Schiaffella E Anderson AO Mage RG Generation hetero geneous rabbit antiDNP antibodies gene conversion hypermuta tion rearranged VL VH genes clonal expansion B cells splenic germinal centers Eur J Immunol 2000 30 36343644 109 Trier JS Structure function intestinal M cells Gastroenterol Clin North Am 1991 20 531547 110 Cooper MD Perey DY Mckneally MF Gabrielsen AE Sutherland DE Good RA A mammalian equivalent avian bursa Fabricius Lancet 1966 1 13881391 111 Bockman DE Functional histology appendix Arch Histol Jpn 1983 46 271292 112 Štěpánková R Kovářů F Immunoglobulinproducing cells lymphatic rabbits detected tissues germfree conventional immunoﬂuorescence method Folia Microbiol 1985 30 291294 113 TlaskalovaHogenova H Stepankova R Development antibody forma tion germfree conventionally reared rabbits role intestinal lymphoid tissue antibody formation E coli antigens Folia Biol 1980 26 8193 114 Lanning D Sethupathi P Rhee KJ Zhai SK Knight KL Intestinal microﬂora diversiﬁcation rabbit antibody repertoire J Immunol 2000 165 20122019 115 Winstead CR Zhai SK Sethupathi P Knight KL Antigeninduced somatic diversiﬁcation rabbit IgH genes gene conversion point mutation J Immunol 1999 162 66026612 116 Schiaffella E Sehgal D Anderson AO Mage RG Gene conversion hypermutation diversiﬁcation VH sequences developing splenic germinal centers immunized rabbits J Immunol 1999 162 39843995 117 SpiekerPolet H Yam PC Knight KL Differential expression 13 IgA heavy chain genes rabbit lymphoid tissues J Immunol 1993 150 54575465 118 Margulies DH Monoclonal antibodies producing magic bullets somatic cell hybridization J Immunol 2005 174 24512452 119 Kohler G Milstein C Continuous cultures fused cells secreting antibody predeﬁned speciﬁcity Nature 1975 256 495497 120 Beerli RR Rader C Mining human antibody repertoires MAbs 2010 2 365378 121 Zhu W Yu GL Rabbit hybdridoma In An Z ed Therapeutic Monoclonal Antibodies From Bench Clinic John Wiley Sons Hoboken NJ USA 2009 pp 151168 122 Raybould TJ Takahashi M Production stable rabbitmouse hybridomas secrete rabbit mAb deﬁned speciﬁcity Science 1988 240 17881790 123 Collins JJ Black PH Strosberg AD Haber E Bloch KJ Transformation simian virus 40 spleen cells hyperimmune rabbit evidence synthesis immunoglobulin transformed cells Proc Natl Acad Sci USA 1974 71 260262 124 Buttin G Leguern G Phalente L Lin EC Medrano L Cazenave PA Production hybrid lines secreting monoclonal antiidiotypic antibodies cell fusion membrane ﬁlters Curr Top Microbiol Immunol 1978 81 2736 125 Yarmush ML Gates FT 3rd Weisfogel DR Kindt TJ Identiﬁcation characterization rabbit immunoglobulin chains Proc Natl Acad Sci USA 1980 77 28992903 rabbitmouse hybridomas secreting 126 Dreher KL Sogn JA Gates FT 3rd Kuo MC Kindt TJ Allotypedeﬁned mRNA rabbit immunoglobulin H L chains isolated rabbit mouse hybridomas J Immunol 1983 130 442448 127 Verbanac KM Gross UM Rebellato LM Thomas JM Production stable rabbitmouse heterohybridomas characterization rabbit monoclonal antibody recognizing 180 kDa human lymphocyte membrane antigen Hybridoma 1993 12 285295 128 SpiekerPolet H Sethupathi P Yam PC Knight KL Rabbit monoclonal antibodies generating fusion partner produce rabbitrabbit hybrido mas Proc Natl Acad Sci USA 1995 92 93489352 129 Yam PC Knight KL Generation rabbit monoclonal antibodies Methods Mol Biol 2014 1131 7179 Rabbit antibodies J Weber et al 11 130 Liguori MJ HoffVelk JA Ostrow DH Recombinant human interleukin6 enhances immunoglobulin secretion rabbitrabbit hybridoma Hybridoma 2001 20 189198 131 Yu J Kane S Wu J Benedettini E Li D Reeves C et al Mutationspeciﬁc detection EGFR mutations nonsmallcell antibodies lung cancer Clin Cancer Res 2009 15 30233028 132 Cameron A Giacomozzi B Joyce J Gray A Graham D Ousson S et al Generation characterization rabbit monoclonal antibody site speciﬁc tau OGlcNAcylated serine 400 FEBS Lett 2013 587 37223728 133 Ghosh P Sahoo R Vaidya A Cantel S Kavishwar A Goldﬁne A et al A speciﬁc sensitive assay blood levels glycated CD59 novel biomarker diabetes Am J Hematol 2013 88 670676 134 Pan R Chen Y Vaine M Hu G Wang S Lu S et al Structural analysis novel rabbit monoclonal antibody R53 targeting epitope HIV1 gp120 C4 region critical receptor coreceptor binding Emerg Microbes Infect 2015 4 e44 135 Qin Y Banerjee S Agrawal A Shi H Banasik M Lin F et al Characterization large panel rabbit monoclonal antibodies HIV1 gp120 isolation novel neutralizing antibodies V3 loop PLoS ONE 2015 10 e0128823 136 Chen Y Vaine M Wallace A Han D Wan S Seaman MS et al A novel rabbit monoclonal antibody platform dissect diverse repertoire antibody epitopes HIV1 Env immunogen design J Virol 2013 87 1023210243 137 Smith GP Filamentous fusion phage novel expression vectors display cloned antigens virion surface Science 1985 228 13151317 138 Clackson T Hoogenboom HR Grifﬁths AD Winter G Making antibody fragments phage display libraries Nature 1991 352 624628 139 Barbas CF 3rd Kang AS Lerner RA Benkovic SJ Assembly combinatorial antibody libraries phage surfaces gene III site Proc Natl Acad Sci USA 1991 88 79787982 140 Winter G Grifﬁths AD Hawkins RE Hoogenboom HR Making antibodies phage display technology Annu Rev Immunol 1994 12 433455 141 Rader C Barbas CF 3rd Phage display combinatorial antibody libraries Curr Opin Biotechnol 1997 8 503508 142 Rader C Antibody libraries drug target discovery Drug Discov Today 2001 6 3643 143 Ridder R Schmitz R Legay F Gram H Generation rabbit monoclonal antibody fragments combinatorial phage display library production yeast Pichia pastoris Biotechnology 1995 13 255260 144 Chi XS Landt Y Crimmins DL Dieckgraefe BK Ladenson JH Isolation characterization rabbit single chain antibodies human Reg Ialpha protein J Immunol Methods 2002 266 197207 145 Li Y Collins MS Whitelam GC Alexander DJ Rapid pathotyping Newcastle disease virus singlechain Fv displayed phage Cterminal end F2 polypeptide Arch Virol 2002 147 20252037 146 CorteReal S Collins C Aires Da Silva F Simas JP Barbas CF 3rd Chang Y et al Intrabodies targeting Kaposi sarcomaassociated herpesvirus latency antigen inhibit viral persistence lymphoma cells Blood 2005 106 37973802 147 Nelson JD Kinkead H Brunel FM Leaman D Jensen R Louis JM et al Antibody elicited gp41 Nheptad repeat NHR coiledcoil neutralize HIV1 modest potency nonneutralizing antibodies bind NHR mimetics Virology 2008 377 170183 148 Moon SA Ki MK Lee S Hong ML Kim M Kim S et al Antibodies nonimmunizing antigens derived large immune scFv library Mol Cells 2011 31 509513 149 Ma H Meng J Wang J Hearty S Dolly JO Okennedy R Targeted delivery SNARE protease sensory neurons single chain antibody scFv extracellular domain P2X3 inhibits release pain mediator Biochem J 2014 462 247256 150 Gough KC Maddison BC Shikotra A Moiseeva EP Yang W Jarvis S et al Evidence novel Kit adhesion domain mediating human mast cell adhesion structural airway cells Respir Res 2015 16 86 151 Da Silva FA Li M Rato S Maia S Malho R Warren K et al Recombinant rabbit singlechain antibodies bind catalytic Cterminal domains HIV1 integrase protein strongly inhibit HIV1 replication Biotechnol Appl Biochem 2012 59 353366 152 Lang IM Barbas CF 3rd Schleef RR Recombinant rabbit Fab binding activity type1 plasminogen activator inhibitor derived phagedisplay library human alphagranules Gene 1996 172 295298 Experimental Molecular Medicine Rabbit antibodies J Weber et al 12 153 Foti M Granucci F RicciardiCastagnoli P Spreaﬁco A Ackermann M Suter M Rabbit monoclonal Fab derived phage display library J Immunol Methods 1998 213 201212 154 Rader C Generation selection rabbit antibody libraries phage display Methods Mol Biol 2009 525 101128xiv 155 Rader C Ritter G Nathan S Elia M Gout I Jungbluth AA et al The rabbit antibody repertoire novel source generation therapeutic human antibodies J Biol Chem 2000 275 1366813676 156 Popkov M Rader C Barbas CF 3rd Isolation human prostate cancer cell reactive antibodies phage display technology J Immunol Methods 2004 291 137151 157 Lee S Yoon IH Yoon A CookMills JM Park CG Chung J An antibody sixth Iglike domain VCAM1 inhibits leukocyte transendothelial Immunol 2012 189 migration adhesion 45924601 affecting J 158 Cho AY Shin KJ Chung J Oh S A sensitive enzyme immunoassay amygdalin food extracts recombinant antibody J Food Prot 2008 71 20482052 159 Lee MS Lee JC Choi CY Chung J Production characterization monoclonal antibody botulinum neurotoxin type B light chain phage display Hybridoma 2008 27 1824 160 Goncalves J Silva F FreitasVieira A SantaMarta M Malho R Yang X et al Functional neutralization HIV1 Vif protein intracellular immunization inhibits reverse transcription viral replication J Biol Chem 2002 277 3203632045 161 Hofer T Tangkeangsirisin W Kennedy MG Mage RG Raiker SJ Venkatesh K et al Chimeric rabbithuman Fab IgG speciﬁc members Nogo66 receptor family selected species cross reactivity improved phage display vector J Immunol Methods 2007 318 7587 162 Zhuang X Stahl SJ Watts NR Dimattia MA Steven AC Wingﬁeld PT A cellpenetrating antibody fragment HIV1 Rev high antiviral activity characterization paratope J Biol Chem 2014 289 2022220233 163 Holliger P Hudson PJ Engineered antibody fragments rise single domains Nat Biotechnol 2005 23 11261136 164 Hudson PJ Kortt AA High avidity scFv multimers diabodies triabodies J Immunol Methods 1999 231 177189 165 Jendreyko N Popkov M Beerli RR Chung J Mcgavern DB Rader C et al Intradiabodies bispeciﬁc tetravalent antibodies simultaneous functional knockout cell surface receptors J Biol Chem 2003 278 4781247819 166 Jendreyko N Popkov M Rader C Barbas CF 3rd Phenotypic knockout VEGFR2 Tie2 intradiabody reduces tumor growth angiogenesis vivo Proc Natl Acad Sci USA 2005 102 82938298 167 Popkov M Jendreyko N Mcgavern DB Rader C Barbas CF 3rd Targeting tumor angiogenesis adenovirusdelivered antiTie2 intrabody Cancer Res 2005 65 972981 168 Suter M Blaser K Aeby P Crameri R Rabbit single domain antibodies speciﬁc protein C expressed prokaryotes Immunol Lett 1992 33 5359 169 Aires Da Silva F SantaMarta M FreitasVieira A Mascarenhas P Barahona I MonizPereira J et al Camelized rabbitderived VH single domain intrabodies Vif strongly neutralize HIV1 infectivity J Mol Biol 2004 340 525542 170 CunhaSantos C Figueira TN Borrego P Oliveira SS Rocha C Couto A et al Development synthetic lightchain antibodies novel potent HIV fusion inhibitors AIDS 2016 30 16911701 171 Yu X Mcgraw PA House FS Crowe JE Jr An optimized electrofusion based protocol generating virusspeciﬁc human monoclonal antibo dies J Immunol Methods 2008 336 142151 172 Seeber S Ros F Thorey I Tiefenthaler G Kaluza K Lifke V et al A robust high throughput platform generate functional recombinant monoclonal antibodies rabbit B cells peripheral blood PLoS ONE 2014 9 e86184 173 OjimaKato T Hashimura D Kojima T Minabe S Nakano H In vitro generation rabbit antiListeria monocytogenes monoclonal antibody single cell based RTPCR linked cellfree expression systems J Immunol Methods 2015 427 5865 174 Babcook JS Leslie KB Olsen OA Salmon RA Schrader JW A novel strategy generating monoclonal antibodies single isolated lymphocytes producing antibodies deﬁned speciﬁcities Proc Natl Acad Sci USA 1996 93 78437848 Experimental Molecular Medicine 175 Ozawa T Piao X Kobayashi E Zhou Y Sakurai H Andoh T et al A novel rabbit immunospot array assay chip allows rapid generation rabbit monoclonal antibodies high afﬁnity PLoS ONE 2012 7 e52383 176 Lightwood DJ Carrington B Henry AJ Mcknight AJ Crook K Cromie K et al Antibody generation B cell panning antigen followed situ culture direct RTPCR cells harvested en masse antigenpositive wells J Immunol Methods 2006 316 133143 177 Starkie DO Compson JE Rapecki S Lightwood DJ Generation recombinant monoclonal antibodies immunised mice rabbits ﬂow cytometry sorting antigenspeciﬁc IgG memory B cells PLoS ONE 2016 11 e0152282 178 Kivi G Teesalu K Parik J Kontkar E Ustav M Jr Noodla L et al HybriFree robust rapid method development monoclonal antibodies different host species BMC Biotechnol 2016 16 2 179 Clargo AM Hudson AR Ndlovu W Wootton RJ Cremin LA Odowd VL et al The rapid generation functional monoclonal antibodies individual antigenspeciﬁc bone marrowderived plasma cells isolated novel ﬂuorescencebased method MAbs 2014 6 143159 recombinant 180 Georgiou G Ippolito GC Beausang J Busse CE Wardemann H Quake SR The promise challenge highthroughput sequencing antibody repertoire Nat Biotechnol 2014 32 158168 181 Cheung WC Beausoleil SA Zhang X Sato S Schieferl SM Wieler JS identiﬁcation cloning serum Nat Biotechnol 2012 30 et al A proteomics approach monoclonal antibodies 447452 182 Hwang WY Foote J Immunogenicity engineered antibodies Methods 2005 36 310 183 Chatenoud L Jonker M Villemain F Goldstein G Bach JF The human immune response OKT3 monoclonal antibody oligoclonal Science 1986 232 14061408 184 Grossbard ML Press OW Appelbaum FR Bernstein ID Nadler LM Monoclonal antibodybased therapies leukemia lymphoma Blood 1992 80 863878 185 Morrison SL Johnson MJ Herzenberg LA Oi VT Chimeric human antibody molecules mouse antigenbinding domains human region domains Proc Natl Acad Sci USA 1984 81 constant 68516855 186 Jones PT Dear PH Foote J Neuberger MS Winter G Replacing complementaritydetermining regions human antibody mouse Nature 1986 321 522525 187 Zhang YF Phung Y Gao W Kawa S Hassan R Pastan I et al New high afﬁnity monoclonal antibodies recognize nonoverlapping epitopes mesothelin monitoring treating mesothelioma Sci Rep 2015 5 9928 188 Steinberger P Sutton JK Rader C Elia M Barbas CF 3rd Generation characterization recombinant human CCR5speciﬁc antibody A phage display approach rabbit antibody humanization J Biol Chem 2000 275 3607336078 189 Waldmeier L Hellmann I Gutknecht CK Wolter FI Cook SC Reddy ST et al TranspomAb display transpositionmediated B cell display functional screening fulllength IgG antibody libraries MAbs 2016 8 726740 190 Rader C Cheresh DA Barbas CF 3rd A phage display approach rapid antibody humanization designed combinatorial V gene libraries Proc Natl Acad Sci USA 1998 95 89108915 191 Weiner LM Dhodapkar MV Ferrone S Monoclonal antibodies cancer immunotherapy Lancet 2009 373 10331040 This work licensed Creative Commons AttributionNonCommercialShareAlike 40 Inte rnational License The images party material article included articles Creative Commons license indicated credit line material included Creative Commons license users need obtain permission license holder reproduce material To view copy license visit httpcreativecommonsorglicensesbyncsa40